Pfizer Inc (NYSE:PFE) traded at $26.89 at close of the session on Monday, January 06 and made an upward move of 1.13% on its previous day’s price.
Looking at the stock we see that its previous close was $26.59 and the beta (5Y monthly) reads 0.615 with the day’s price range being $26.56 – $27.25. The company has a trailing 12-month PE ratio of 36.15. In terms of its 52-week price range, PFE has a high of $31.54 and a low of $24.48. The company’s stock has gained about 6.58% over that past 30 days.
Pfizer Inc has a market cap of $152.27 billion and is expected to release its quarterly earnings report in February. With its Forward Dividend at 1.68 and a yield of 6.25%, the company’s investors could be anxious for the PFE stock to gain ahead of the earnings release.
On the other hand, looking at the outlook for the PFE stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 16 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 7 have rated the Pfizer Inc (PFE) stock as a Hold, while 7 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the PFE stock currently stands at 3.61, and the current price level is 2.84% off its SMA20 and 1.74% from its 50-day simple moving average. The RSI (14) is pointing at 57.86 while the volatility over the past week is 1.47% and jumps to 1.93% over the past one month. The beta value is 0.61, while the average true range (ATR) is currently pointing at 0.51. The average price target for the stock over the next 12 months is $32, with the estimates having a low of $30 and a high of $36. These price ends are -11.57% and -33.88% off the current price level respectively, although investors could be excited at the prospect of a -19.0% if the PFE share price touches on the median price of $32.
Coming back to Pfizer Inc (NYSE:PFE), we note that the average 3-month trading volume was 42.89 million, while that of the preceding 10-day period stands at 41.46 million. Current shares outstanding are 5.67 billion.
The insiders hold 0.03% of the company’s shares while institutions hold 67.56%. The data shows that short shares as of 2024-12-13, stood at 85.37 million at a short ratio of 1.85. This represents a 151.00 short interest in shares outstanding on 2024-12-13. Shares short fall in December from the previous month at 94.54 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 1.36% up in year-to-date price movement.
